JP2005500325A5 - - Google Patents

Download PDF

Info

Publication number
JP2005500325A5
JP2005500325A5 JP2003511875A JP2003511875A JP2005500325A5 JP 2005500325 A5 JP2005500325 A5 JP 2005500325A5 JP 2003511875 A JP2003511875 A JP 2003511875A JP 2003511875 A JP2003511875 A JP 2003511875A JP 2005500325 A5 JP2005500325 A5 JP 2005500325A5
Authority
JP
Japan
Prior art keywords
group
independently
formula
compound
chelating agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003511875A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005500325A (ja
JP5015409B2 (ja
Filing date
Publication date
Priority claimed from GBGB0116815.2A external-priority patent/GB0116815D0/en
Application filed filed Critical
Publication of JP2005500325A publication Critical patent/JP2005500325A/ja
Publication of JP2005500325A5 publication Critical patent/JP2005500325A5/ja
Application granted granted Critical
Publication of JP5015409B2 publication Critical patent/JP5015409B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003511875A 2001-07-10 2002-07-10 改良キレート剤結合体 Expired - Lifetime JP5015409B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0116815.2A GB0116815D0 (en) 2001-07-10 2001-07-10 Improved chelator conjugates
GB0116815.2 2001-07-10
PCT/GB2002/003168 WO2003006070A2 (en) 2001-07-10 2002-07-10 Improved chelator conjugates

Publications (3)

Publication Number Publication Date
JP2005500325A JP2005500325A (ja) 2005-01-06
JP2005500325A5 true JP2005500325A5 (cg-RX-API-DMAC7.html) 2006-01-05
JP5015409B2 JP5015409B2 (ja) 2012-08-29

Family

ID=9918227

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003511875A Expired - Lifetime JP5015409B2 (ja) 2001-07-10 2002-07-10 改良キレート剤結合体

Country Status (20)

Country Link
US (2) US7597875B2 (cg-RX-API-DMAC7.html)
EP (1) EP1404377B1 (cg-RX-API-DMAC7.html)
JP (1) JP5015409B2 (cg-RX-API-DMAC7.html)
KR (1) KR100892009B1 (cg-RX-API-DMAC7.html)
CN (4) CN101537190A (cg-RX-API-DMAC7.html)
AT (1) ATE304866T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002317317B2 (cg-RX-API-DMAC7.html)
BR (1) BR0210965A (cg-RX-API-DMAC7.html)
CA (1) CA2450690C (cg-RX-API-DMAC7.html)
DE (1) DE60206272T2 (cg-RX-API-DMAC7.html)
DK (1) DK1404377T3 (cg-RX-API-DMAC7.html)
ES (1) ES2250671T3 (cg-RX-API-DMAC7.html)
GB (1) GB0116815D0 (cg-RX-API-DMAC7.html)
HU (1) HU228850B1 (cg-RX-API-DMAC7.html)
IL (1) IL159388A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA04000210A (cg-RX-API-DMAC7.html)
NO (1) NO334093B1 (cg-RX-API-DMAC7.html)
RU (1) RU2298012C2 (cg-RX-API-DMAC7.html)
WO (1) WO2003006070A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200400143B (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002054088A2 (en) 2001-01-05 2002-07-11 Duke University Contrast enhancement agent for magnetic resonance imaging
CN1622830A (zh) * 2001-07-10 2005-06-01 安盛药业有限公司 肽基化合物
NO20030115D0 (no) 2003-01-09 2003-01-09 Amersham Health As Kontrastmiddel
EP1699495A2 (en) * 2003-11-06 2006-09-13 Amersham Health AS Conjugates of angiotensin ii and an imaging moiety
GB0416062D0 (en) * 2004-07-19 2004-08-18 Amersham Plc Improved N4 chelator conjugates
US7431914B2 (en) 2003-11-24 2008-10-07 Ge Healthcare As Contrast agent
DE602005017475D1 (de) * 2004-03-04 2009-12-17 Ge Healthcare As Konjugate von angiotensin-peptid analoga und chelatbildner für diagnose und therapie
KR20070091609A (ko) 2004-11-22 2007-09-11 지이 헬스케어 에이에스 세포외 기질을 표적화하기 위한 조영제
GB0427392D0 (en) * 2004-12-15 2005-01-19 Amersham Plc Stabilised 99mTc compositions
WO2006131803A2 (en) * 2005-06-08 2006-12-14 Ge Healthcare Limited Method for the use of [11c] carbon monoxide in labeling synthesis of 11c-labelled esters and acids by sensitized photo-induced free radical carbonylation
GB0515974D0 (en) * 2005-08-03 2005-09-07 Ge Healthcare Ltd Compounds and imaging methods
JP5290773B2 (ja) 2006-02-15 2013-09-18 ジーイー・ヘルスケア・アクスイェ・セルスカプ 造影剤
US7943117B2 (en) * 2006-06-08 2011-05-17 Atomic Energy Council—Institute of Nuclear Research Method for testing radiochemical purity of Tc-99m-TRODAT-1
ES2346595T3 (es) * 2006-12-11 2010-10-18 Ge Healthcare As Compuestos basados en peptidos radiomarcados y usos de los mismos.
DK3098225T3 (en) 2008-12-02 2019-03-25 Univ Melbourne NITROGEN CONTAINING MACROCYCLIC CONJUGATES AS RADIO PHARMACY
GB0922014D0 (en) 2009-12-17 2010-02-03 Ge Healthcare Ltd Novel integrin binders
ES2804509T3 (es) 2010-07-27 2021-02-08 Serac Healthcare Ltd Composiciones radiofarmacéuticas
GB201103696D0 (en) * 2011-03-04 2011-04-20 Ge Healthcare Ltd Technetium labelled peptides
GB201110767D0 (en) 2011-06-24 2011-08-10 Ge Healthcare Ltd Infection imaging
US20130195756A1 (en) 2012-01-31 2013-08-01 General Electric Company 99mTc IMAGING AGENTS AND METHODS OF USE
AU2014216515A1 (en) * 2013-02-15 2015-10-08 Thomas Jefferson University Kit for tumor imaging
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
GB201322456D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
WO2015140212A1 (en) 2014-03-19 2015-09-24 Universität Zürich Multidentate bifunctional chelating agents for radionuclide complexation in diagnostics and therapy
JP7495126B2 (ja) * 2018-05-08 2024-06-04 ユニヴァーシティー オブ マイアミ 組織への治療用核酸の送達のための材料および方法
US11844846B2 (en) 2018-05-16 2023-12-19 Emory University Styrylbenzothiazole derivatives and uses in imaging methods
CN111548275A (zh) * 2020-05-27 2020-08-18 龙曦宁(上海)医药科技有限公司 一种2-(氨基甲基)-n1,n1-二甲基丙烷-1,3-二胺三盐酸盐的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1588978A (en) * 1977-07-19 1981-05-07 Ici Ltd Coating processes
DE3930674A1 (de) * 1989-09-11 1991-03-21 Diagnostikforschung Inst Bifunktionelle chelatbildner zur komplexierung von tc- und re-isotopen, verfahren zu ihrer herstellung und darstellung von konjugaten daraus sowie deren verwendung in diagnostik und therapie
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
US5808091A (en) * 1991-10-29 1998-09-15 Bracco International B.V. Rhenium and technetium complexes containing a hypoxia localizing moiety
HUT73672A (en) * 1993-08-04 1996-09-30 Amersham Int Plc Radiometal complexes that localise in hypoxic tissue
ES2114735T3 (es) * 1994-01-12 1998-06-01 Bracco Int Bv Ligandos y complejos metalicos de los mismos.
US5705143A (en) * 1994-01-12 1998-01-06 Amersham International Plc Biological targeting agents
DE69937996T2 (de) * 1998-05-15 2009-01-02 Ge Healthcare Ltd., Little Chalfont Markierte glutamin- und lysinanaloge
US6783711B2 (en) * 2000-05-23 2004-08-31 Ge Osmonics, Inc. Process for preparing a sulfonamide polymer matrix
US6988794B2 (en) * 2001-03-08 2006-01-24 Matsushita Electric Industrial Co., Ltd. Inkjet recording ink, method for producing said ink, and ink cartridge and recording device having said ink

Similar Documents

Publication Publication Date Title
JP2005500325A5 (cg-RX-API-DMAC7.html)
RU2003137592A (ru) Улучшенные хелатные конъюгаты
JP2021073272A5 (cg-RX-API-DMAC7.html)
JP2005053931A5 (cg-RX-API-DMAC7.html)
PE20090611A1 (es) Procedimiento para sintetizar compuestos utiles para tratar hepatitis c
JP2010514786A5 (cg-RX-API-DMAC7.html)
JP2008509166A5 (cg-RX-API-DMAC7.html)
EP2311851A3 (en) Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
JP2005511697A5 (cg-RX-API-DMAC7.html)
JP2003306481A5 (cg-RX-API-DMAC7.html)
JP2002508375A5 (cg-RX-API-DMAC7.html)
EP2308828A3 (en) CaSR antagonist
JP2010505865A5 (cg-RX-API-DMAC7.html)
HRP20121026T1 (hr) Postupak za dobivanje kaspofungina i njegovih intermedijera
JP2005536503A5 (cg-RX-API-DMAC7.html)
JP2001261662A5 (cg-RX-API-DMAC7.html)
CA2530584A1 (en) Composition and method for diversion agents for acid stimulation of subterranean formations
JP2012518649A5 (cg-RX-API-DMAC7.html)
RU2003134629A (ru) Соединения цефема
EP2551266A8 (en) 2',2-dithiazol non-nucleoside compounds, preparation methods, pharmaceutical compositions and uses as hepatitis virus inhibitors thereof
JP2004538278A5 (cg-RX-API-DMAC7.html)
JP2005514512A5 (cg-RX-API-DMAC7.html)
JP2005516898A5 (cg-RX-API-DMAC7.html)
JP2008530106A5 (cg-RX-API-DMAC7.html)
JP2006514013A5 (cg-RX-API-DMAC7.html)